Tasly Pharmaceutical Group Co Ltd Net Asset Quality Index

Latest as of June 2026: 86.3%

Tasly Pharmaceutical Group Co Ltd net asset quality index. Tasly Pharmaceutical Group Co Ltd (600535) has a Net Asset Quality Index of 86.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥15.30 Billion minus total liabilities of CN¥2.09 Billion yields net assets of CN¥13.21 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See what is Tasly Pharmaceutical Group Co Ltd's book value for net asset value and shareholders' equity analysis.

Quality Index

86.3%
Equity / Total Assets

Net Assets

CN¥13.21 Billion
CNY

Total Assets

CN¥15.30 Billion
CNY

Total Liabilities

CN¥2.09 Billion
CNY

Net Asset Quality Index of Tasly Pharmaceutical Group Co Ltd (1999–2025)

Net asset quality index of Tasly Pharmaceutical Group Co Ltd from 1999 to 2025. This chart shows how Tasly Pharmaceutical Group Co Ltd's Net Asset Quality Index has evolved across 27 annual periods from 1999 to 2025. As of June 2026, the index stands at 86.3%, representing net assets of CN¥13.21 Billion against total assets of CN¥15.30 Billion CNY. Check Tasly Pharmaceutical Group Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Tasly Pharmaceutical Group Co Ltd Net Asset Quality Index by Year (1999–2025)

Tasly Pharmaceutical Group Co Ltd net asset quality index by year from 1999 to 2025. The table below presents the year-by-year Net Asset Quality Index for Tasly Pharmaceutical Group Co Ltd from 1999 to 2025, covering 27 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Tasly Pharmaceutical Group Co Ltd market capitalisation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 81.8% CN¥12.55 Billion CN¥15.34 Billion CN¥2.79 Billion ▲ +0.9 pp
2024 80.9% CN¥12.11 Billion CN¥14.98 Billion CN¥2.87 Billion ▲ +4.9 pp
2023 75.9% CN¥12.69 Billion CN¥16.71 Billion CN¥4.02 Billion ▼ -1.0 pp
2022 76.9% CN¥12.63 Billion CN¥16.43 Billion CN¥3.80 Billion ▼ -3.6 pp
2021 80.5% CN¥13.31 Billion CN¥16.54 Billion CN¥3.23 Billion ▲ +5.4 pp
2020 75.1% CN¥12.38 Billion CN¥16.49 Billion CN¥4.11 Billion ▲ +25.7 pp
2019 49.4% CN¥11.86 Billion CN¥24.01 Billion CN¥12.15 Billion ▲ +4.9 pp
2018 44.5% CN¥11.21 Billion CN¥25.17 Billion CN¥13.96 Billion ▲ +2.8 pp
2017 41.7% CN¥8.97 Billion CN¥21.53 Billion CN¥12.56 Billion ▼ -6.2 pp
2016 47.9% CN¥8.21 Billion CN¥17.13 Billion CN¥8.92 Billion ▼ -2.1 pp
2015 50.0% CN¥7.71 Billion CN¥15.41 Billion CN¥7.71 Billion ▲ +10.8 pp
2014 39.2% CN¥5.07 Billion CN¥12.92 Billion CN¥7.85 Billion ▼ -1.3 pp
2013 40.6% CN¥4.14 Billion CN¥10.21 Billion CN¥6.07 Billion ▼ -15.6 pp
2012 56.2% CN¥4.21 Billion CN¥7.49 Billion CN¥3.28 Billion ▼ -0.7 pp
2011 56.9% CN¥3.78 Billion CN¥6.63 Billion CN¥2.86 Billion ▼ -5.9 pp
2010 62.8% CN¥3.42 Billion CN¥5.45 Billion CN¥2.03 Billion ▲ +8.9 pp
2009 53.9% CN¥2.17 Billion CN¥4.03 Billion CN¥1.85 Billion ▼ -6.8 pp
2008 60.7% CN¥2.09 Billion CN¥3.45 Billion CN¥1.36 Billion ▼ -3.1 pp
2007 63.8% CN¥1.97 Billion CN¥3.09 Billion CN¥1.12 Billion ▲ +11.1 pp
2006 52.8% CN¥1.72 Billion CN¥3.26 Billion CN¥1.54 Billion ▼ -4.0 pp
2005 56.8% CN¥1.56 Billion CN¥2.75 Billion CN¥1.19 Billion ▼ -5.6 pp
2004 62.5% CN¥1.37 Billion CN¥2.20 Billion CN¥826.42 Million ▼ -5.2 pp
2003 67.6% CN¥1.20 Billion CN¥1.78 Billion CN¥575.74 Million ▼ -12.1 pp
2002 79.7% CN¥997.00 Million CN¥1.25 Billion CN¥253.70 Million ▲ +38.2 pp
2001 41.5% CN¥247.20 Million CN¥595.39 Million CN¥348.19 Million ▲ +4.3 pp
2000 37.2% CN¥156.32 Million CN¥420.47 Million CN¥264.15 Million ▼ -1.4 pp
1999 38.5% CN¥135.05 Million CN¥350.34 Million CN¥215.29 Million —
pp = percentage points